Company profile
Pharmatics
Pharmatics Limited is a UK company with status active founded in 2011 based in Scotland.
Financial period: 1 Jan 2024 to 31 Dec 2024
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
CS01 | Transaction MzQ1NjA4MDMyNGFkaXF6a2N4
Published 22 Feb 2025 09:04
Last accounts made up date
AA | Transaction MzQzNzE4NDYzNmFkaXF6a2N4
Published 25 Sep 2024 11:27
Company registered at Companies House
Pharmatics is a startup company developing intelligent software and providing data mining services to industries. We are developing software that can be used to validate causal pathways that may contain therapeutic targets, and identify biomarkers that can be used as surrogate end-points in Phase 2 trials. We are also developing tools for prediction of individual response from high-dimensional -omic measurements. More details are given at www.pharmaticsltd.co.uk
Pharmatics is a young RnD company. It is working on a pilot project with a company listed on FTSE100. In July 2011, Pharmatics was announced the overall winner of BioQuarter Innovation Competition 2011, showing a potential for becoming one of the most promising young bio-medical companies in Scotland.
1 Apr 2024 to 31 Mar 2025
The BIOVIT Personalised Nutrition System will be the most advanced personalised nutrition system in the world, being the first to factor in an individual's tested micronutrient levels, and the first to iteratively re-test and re-formulate personalised nutrition products, thereby creating a positive bio-feedback loop, with the objective of normalising and ...
1 Jan 2024 to 31 Dec 2027
Hypertrophic cardiomyopathy (HCM) is the most common inherited heart disease (prevalence 1:200 - 1:500), manifested by thickening of cardiac walls, increasing risks of arrhythmia, and sudden cardiac death. HCM affects all ages - it is the leading cause of death among young athletes. Comorbidities due to gene mutations include altered vascular control, and...
1 Jun 2020 to 30 Nov 2020
no public description
1 Dec 2019 to 30 Jun 2023
Awaiting Public Project Summary
1 Oct 2019 to 30 Jun 2021
Long-term conditions account for 70% of total medical spending in the UK, and up to 90% in the US. The costs are set to rise as the population is ageing rapidly. Unless there is a change in how long-term conditions are managed, healthcare will become less accessible and more expensive. A solution to this may be self-management, where patients or their car...
1 Aug 2017 to 31 Jul 2018
The frequency of long-term illness worldwide is set to double by 2030, putting a strain on healthcare providers. In some settings, telehealth-based chronic disease management technologies were reported to have remarkable success a solution to this problem. However, other major trials suggest that there is no convincing evidence showing that telehealth sav...
